swissdamed Registration: Key Deadlines, Fees, and Compliance Requirements

The landscape of medical device compliance in Europe remains in a state of constant evolution. Ever since the Mutual Recognition Agreement (MRA) between Switzerland and the European Union was left un-updated under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), Switzerland has forged its own regulatory path.

Because Swiss authorities no longer have active access to the EU’s central database, EUDAMED, Swissmedic – the national surveillance authority for medicines and medical devices – took matters into its own hands. The result is swissdamed (Swiss Database on Medical Devices).

To clarify the rules surrounding this bespoke platform, Swissmedic hosted an industry-wide webinar detailing critical deadlines, newly instituted registration fees, and upcoming system updates. For medical device manufacturers, authorized representatives, and importers, understanding these details is a vital operational necessity.

What is swissdamed?

At its core, swissdamed is Swissmedic’s proprietary registration database. It serves as the single source of truth for all medical devices and in vitro diagnostic (IVD) medical devices placed on the Swiss market.

While it mimics the data models and registration pathways of EUDAMED (supporting manual data entry, XML bulk uploads, and Machine-to-Machine REST API transfers), it functions as an entirely separate entity. Registration in EUDAMED does not satisfy your regulatory obligations in Switzerland.

Currently, swissdamed relies on two primary modules:

1. The Actors Module: For managing economic operators.
2. The UDI Devices Module: For registering unique device identification data.

Crucial Registration Deadlines

To maintain market access, manufacturers must keep a close eye on the calendar. The transition period for swissdamed is active, but it will close rapidly as we head into the new year.

1. UDI Devices

Device registration is mandatory for any individual sales unit placed on the Swiss market as of 1 July 2026. This rule encompasses both regulation-compliant devices and legacy devices.

• The Grace Period: For devices first placed on the market between 1 July 2026 and 31 December 2026, a transition period applies. Manufacturers can continue selling these devices throughout the latter half of 2026 without prior swissdamed registration – provided the registration is fully completed by 31 December 2026.
• The Hard Cut-Off: Beginning 1 January 2027, pre-market registration is mandatory. You cannot place a new device on the Swiss market without registering it first.
• The Exception: If a device is involved in an incident, a Field Safety Corrective Action (FSCA), or a trend report that must be submitted to Swissmedic, it must be registered immediately, bypassing any remaining transition grace periods.

2. Master UDI-DI

For products requiring a Master UDI-DI, the formal obligation begins on 9 November 2026, with the corresponding transition period wrapping up on 31 December 2026.

• Exception: Spectacle frames, spectacle lenses, and ready-to-wear reading glasses have received an extended deadline, with registration obligations pushed out to 1 November 2028.

Understanding the New Swissmedic Fee Structure

Coinciding with the rollout of these requirements, Swissmedic introduced a updated fee ordinance (FeeO-Swissmedic, SR 812.214.5), which went into effect on 1 July 2026.

Unlike recurring annual subscription models, Swissmedic’s database fee is a one-time charge per registered UDI-DI that has its market status set to “On the market.”

Key Fee Rules:

• No Fee for Drafts or Updates: Devices in “Draft” status do not incur charges. Modifying or uploading a new version of an already-registered UDI-DI does not trigger a new charge.
• The Critical Billing Milestone (31 December 2026): Swissmedic will conduct its first fee assessment on December 31, 2026, based on all registered devices marked “On the market” on that date. First invoices will head out in January 2027. If a device is marked “No longer placed on the market” before December 31, no fee is assessed.
• Ongoing Billing: Starting 31 January 2027, invoices will be compiled and sent at the end of each calendar month for any new UDI-DIs registered during that month.

Note on Invoicing: Invoices are directed to the registered Swiss actor. For foreign manufacturers, the invoice is sent directly to their appointed Swiss Authorized Representative (AR).

Managing the Actors Module: Mandates & Transfers

The Actors Module governs economic operators active in Switzerland, recognizing specific Swiss roles:

• Swiss Manufacturer (MF): The entity responsible for the design, manufacture, packaging, and labeling of the device under their name.
• Swiss Authorized Representative (AR): The in-country representative acting on behalf of a foreign manufacturer, managing their Swiss compliance and registration mandates.
• Swiss Importer (IM): The entity placing physical devices from a foreign country onto the Swiss market.
• Swiss Single Practice Procedure (SPP) Producer: The entity responsible for assembling systems or procedure packs within Switzerland.

Crucial AR Mandate Transfers

For foreign manufacturers, your Swiss Authorized Representative is your compliance anchor. If an AR relationship dissolves or becomes inactive, Swissmedic considers all associated mandates “not valid.” Any associated devices marked “On the market” will lose their active status within 30 days unless a transfer is successfully initiated.

To prevent market disruption, Swissmedic has introduced a seamless mandate transfer function. When changing AR partners, the current representative must initiate the transfer directly within swissdamed. This migrates the device list to the new AR under a new Mandate ID without altering active device statuses. Never manually inactivate a mandate during a transition, as doing so will instantly set all linked devices to “No longer placed on the market.”

Step-by-Step: How to Submit Your Data

There are three avenues available to upload your unique device identification data into swissdamed:

1.Choose Your Submission Method:M2M, XML, or Online Editor.

Identify the best method for your data volume. Large portfolios should utilize Machine-to-Machine (M2M) REST APIs (live since June 2026) or XML Bulk Uploads (supporting up to 300 UDI-DIs per upload using standard EUDAMED schema files). Smaller portfolios can use the manual online data editor.

2.Input and Validate Your Device Data:Manufacturer’s Responsibility.

Populate all required UDI fields. As Swissmedic plans to make this database fully downloadable to the public by 2027, data accuracy and quality control rest entirely on the manufacturer.

3.Explicitly Set Market Status to ‘On the market’:Crucial Compliance Step.

Simply uploading your data is not enough. You must manually change the device status to “On the market” to complete registration. Failure to do so means the device is not legally registered for sale.

What’s Coming Next?

Swissmedic’s roadmap for the remainder of 2026 and into 2027 features several important milestones:

• Importer Linking (Autumn 2026): Importers will soon be able to link their actor profiles directly to the devices they handle. Once this feature is live, importers will have until 1 April 2027 to complete their linkings.
• Device Transfer Capabilities: Functional tools to manage device ownership transitions following corporate Mergers & Acquisitions (M&A).
• Public Data Access (By 2027): Publicly searchable download features for registered device data, bringing Swiss transparency in line with EU standards.

Aligning Your Strategy for Swiss and Global UDI Compliance

With the December 31, 2026 deadline fast approaching, medical device companies must act quickly. Proactively registering your portfolio now prevents eleventh-hour system bottlenecks and guarantees that your initial Swissmedic invoicing accurately reflects your active commercial portfolio.

However, managing country-specific databases like swissdamed alongside EUDAMED, the US FDA’s GUDID, and other global registries can quickly overwhelm compliance teams. Relying on disparate, manual processes risks data discrepancies, missed deadlines, and sudden loss of market access.

To streamline your international regulatory strategy, consider partnering with a unified technology solution. Simplify your submission workflow with Visu UDI – the premier global platform for managing and submitting UDI data. Designed to meet evolving global standards, Visu UDI – Global UDI Compliance solutions by DDi provides medical device manufacturers with a centralized, automated hub to manage actor mandates, validate device data, and execute seamless transmissions to registries worldwide. Don’t let shifting regulations stall your market presence; secure your global compliance today.